Indian insurtech startup Plum nets $20 million in Peak XV-led Series B round

Reuters
03/26
Indian insurtech startup Plum nets $20 million in Peak XV-led Series B round

By Haripriya Suresh

BENGALURU, March 26 (Reuters) - Indian corporate insurance startup Plum said on Thursday it has raised 1.93 billion rupees ($20.6 million) as part of its Series B funding round led by Peak XV Partners, valuing the company at 11.81 billion rupees, according to CEO Abhishek Poddar.

GMO Venture Partners and existing investor Tanglin Venture Partners also participated in the round.

The Bengaluru-based company plans to use the fresh capital to scale marketing and sales efforts to expand its presence in India's corporate insurance market, deepen technology investments - particularly in AI-driven claims operations - and expand into preventive and primary healthcare, Poddar said.

Until last year, Plum generated its revenue purely from insurance broking. Its newer healthcare vertical, however, is soon expected to account for a larger share of its revenue mix.

"If I look at the revenue distribution, 80% insurance and 20% healthcare. Very quickly, healthcare has become significant for us, and it's growing in triple digits," Poddar said.

"Our prediction is that healthcare within our corporate business would be roughly 40% to 45% within the next couple of years."

The company is already seeing substantial efficiency gains from AI, especially in claims-processing, which forms the bulk of its operations, Poddar added.

"In the last four years, our claims volume has grown by around 50 times. We have been able to scale by 50 times with a team that would have grown by two times. That's the kind of scale advantage and efficiency advantage that you can generate using AI," he said.

Plum, backed by Tiger Global, counts Meesho MEES.NS, PhonePe PHOP.NS, Swiggy SWIG.NS, Urban Company URBN.NS and Zomato ETEA.NS among its clients.

($1 = 93.8860 Indian rupees)

(Reporting by Haripriya Suresh in Bengaluru; Editing by Sumana Nandy)

((haripriya.suresh@thomsonreuters.com))

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10